In 2019, Musk claimed his company’s device would eventually allow people to achieve a “symbiosis with artificial intelligence." The company, founded in 2016, is still far from merging our brains with AI. In a livestreamed “show and tell” event Wednesday evening, the Neuralink team presented a grab bag of improvements to its technology. Musk did say that Neuralink has begun submitting paperwork for a human clinical trial to the Food and Drug Administration and hopes to implant a Neuralink device in a patient in six months. He revealed that the company’s first two intended applications for its technology would be to help people with paralysis use their digital devices seamlessly and to restore vision in those who have lost their eyesight.
